Sky Labs' CART BP pro ring meets clinical standards for cuffless blood pressure monitoring and achieved regulatory clearance across major markets. The device demonstrates that wearable continuous monitoring can achieve accuracy equivalent to traditional methods, expanding clinical adoption pathways for non-invasive cardiovascular surveillance.
Key Points
- Meets ISO 81060-2:2018 standard and ESH validation criteria
- 260,000+ prescriptions in South Korea; CE-MDR and MHRA cleared
- Enables continuous ambulatory monitoring without traditional cuff apparatus
Longevity Analysis
Continuous blood pressure monitoring represents a substantial shift in cardiovascular risk assessment from episodic measurement to longitudinal signal tracking. Most individuals receive blood pressure readings minutes per year in clinic settings, missing the dynamic patterns that predict cardiovascular events and organ damage. A validated wearable device that operates continuously across daily contexts captures the physiological responses to stress, sleep, movement, nutrition, and temperature—revealing how interventions actually modify cardiovascular function rather than relying on snapshot readings. This transforms blood pressure from a diagnostic endpoint into actionable feedback for protocol implementation and adaptation, supporting the ability to decode vascular system behavior and execute evidence-informed modifications with real-time validation.
Original published by LT Wire.